Chromone-3-aldehyde derivatives – sirtuin 2 inhibitors for correction of muscular dysfunction

1. Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418-E438.Search in Google Scholar

2. Gea J, Barreiro E, Orozco-Levi M. Skeletal muscle adaptation to disease states. In: Bottinelli R, Reggiani C, editors. Skeletal Muscle Plasticity in Health and Disease: From genes to whole muscle. Dordrecht: Springer, 2006: 315-60.Search in Google Scholar

3. Staud R. Peripheral and Central Mechanisms of Fatigue in Inflammatory and Non-Inflammatory Rheumatic Diseases. Curr Rheum. Rep. 2012;14(6):539-48.Search in Google Scholar

4. Chen W-C, Hsu Y-J, Lee M-C, et al. Effect of burdock extract on physical performance and physiological fatigue in mice. J Vet. Medi. Sc. 2017;79(10):1698-706.Search in Google Scholar

5. Johannes F, Jan W, Lutz V, Winfried B., Preventive and Regenerative Foam Rolling are Equally Effective in Reducing Fatigue-Related Impairments of Muscle Function following Exercise. J Sports Sci Med. 2017; 16(4): 474-9.Search in Google Scholar

6. Stults-Kolehmainen MA, Sinha R. The Effects of Stress on Physical Activity and Exercise. Sp. Med. (Auckland, NZ). 2014;44(1):81-121.Search in Google Scholar

7. Fridén-Saxin M, Seifert T, Landergren MR, et al. Synthesis and Evaluation of Substituted Chroman-4-one and Chromone Derivatives as Sirtuin 2-Selective Inhibitors. J Med Chem. 2012;55(16):7104-13.10.1021/jm3005288342619022746324Search in Google Scholar

8. Lee H, Lee K, Jung JK, Cho J, Theodorakis EA. Synthesis and evaluation of 6-hydroxy-7-methoxy-4-chromanone- and chroman-2-carboxamides as antioxidants. Bioorg Med Chem Lett. 2005;15(11): 2745-4810.1016/j.bmcl.2005.03.11815911250Search in Google Scholar

9. Afifi TH, Okasha RM, Ahmed HEA, Ilaš J, Saleh T, Abd-El-Aziz AS. Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents. EXCLI J. 2017;16: 868-902.Search in Google Scholar

10. Dang W. The controversial world of sirtuins. Drug Discov Today Technol. 2014 Jun;12:e9-e17.10.1016/j.ddtec.2012.08.003410154425027380Search in Google Scholar

11. Arora A, Dey CS. SIRT2 negatively regulates insulin resistance in C2C12 skeletal muscle cells. Biochim Biophys Acta. 2014;1842(9): 1372-8.10.1016/j.bbadis.2014.04.02724793418Search in Google Scholar

12. Finney DJ. Probit Analysis: A Statistical Treatment of the Sigmoid Response Curve. Cambridge University Press, London and New York, 1947.Search in Google Scholar

13. Gregory NS, Gibson-Corley K, Frey-Law L, Sluka KA. Fatigue-enhanced hyperalgesia in response to muscle insult: induction and development occur in a sex-dependent manner. Pain. 2013;154(12): 2668-76.10.1016/j.pain.2013.07.047395741623906552Search in Google Scholar

14. Rutherford G, Manning P, Newton JL. Understanding Muscle Dysfunction in Chronic Fatigue Syndrome. J Aging Res. 2016; 2016:2497348.10.1155/2016/2497348477981926998359Search in Google Scholar

15. Budayeva HG, Cristea IM. Human Sirtuin 2 Localization, Transient Interactions, and Impact on the Proteome Point to Its Role in Intracellular Trafficking. Mol Cell Proteomics. 2016;15(10):3107-25.10.1074/mcp.M116.061333505433827503897Search in Google Scholar

16. Houtkooper RH, Pirinen E, Auwerx J. Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012;13(4): 225-38.10.1038/nrm3293487280522395773Search in Google Scholar

17. Jing E, Gesta S, Ronald Kahn C. Sirt2 Regulates Adipocyte Differentiation Involving FoxO1 Acetylation/Deacetylation. Cell Met. 2007;6(2):105-14.10.1016/j.cmet.2007.07.003208363517681146Search in Google Scholar

18. Lara E, Mai A, Calvanese V, Altucci L, Lopez-Nieva P, et al. Salermide, a sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene. 2009; 28: 781-91.10.1038/onc.2008.43619060927Search in Google Scholar

19. Hwang SL, Jeong YT, Li X, Kim YD, Lu Y, Chang YC, Lee IK, Chang HW. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle. Br J Pharmacol. 2013;169:69-81.10.1111/bph.12124363223923373714Search in Google Scholar

20. Chiu TT, Sun Y, Koshkina A. KlipRac-1 superactivation triggers insulin-independent glucose transporter 4 (GLUT4) translocation that bypasses signaling defects exerted by c-Jun N-terminal kinase (JNK) - and ceramide-induced insulin resistance. J Biol Chem. 2013; 288:17520-31.10.1074/jbc.M113.467647368255123640896Search in Google Scholar

21. Kurylowicz A. In Search of New Therapeutic Targets in Obesity Treatment: Sirtuins. Arai T, ed. Int J Mol Sc. 2016;17(4):572.10.3390/ijms17040572484902827104517Search in Google Scholar